Screener
Design Therapeutics, Inc. DSGN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $12,770 | $16,856 |
| Investment securities | 210,053 | 202,989 |
| Prepaid expenses and other current assets | 4,226 | 3,939 |
| Total current assets | 227,049 | 223,784 |
| Property and equipment, net | 824 | 981 |
| Right-of-use asset | 2,569 | 1,438 |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s short-term investments?
- Design Therapeutics, Inc. (DSGN) reported short-term investments of $210.05M in Q1 2026.
- How has Design Therapeutics, Inc.'s short-term investments changed year-over-year?
- Design Therapeutics, Inc.'s short-term investments decreased by 2.8% year-over-year, from $216.01M to $210.05M.
- What is the long-term trend for Design Therapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s short-term investments has grown at a 43.2% compound annual growth rate (CAGR), from $33.71M to $202.99M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Design Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude